Afyren SAS (ALAFY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Afyren SAS (ALAFY) has a cash flow conversion efficiency ratio of -0.044x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.74 Million ≈ $-3.20 Million USD) by net assets (€62.95 Million ≈ $73.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Afyren SAS to measure how many days the company can operate on defensive assets alone.
Afyren SAS - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Afyren SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Afyren SAS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Afyren SAS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Atenor SA
BR:ATEB
|
0.134x |
|
Huddly AS
OL:HDLY
|
-0.003x |
|
ReFuels N.V.
OL:REFL
|
N/A |
|
OMER S.P.A. O.N.
F:9WR
|
N/A |
|
Ester Industries Limited
NSE:ESTER
|
0.033x |
|
Marfin Investment Group Holdings S.A
AT:MIG
|
0.026x |
|
Roadzen Inc.
NASDAQ:RDZN
|
0.000x |
|
Clover Corporation Ltd
AU:CLV
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Afyren SAS (2019–2025)
The table below shows the annual cash flow conversion efficiency of Afyren SAS from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Afyren SAS (ALAFY) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €62.95 Million ≈ $73.60 Million |
€-5.09 Million ≈ $-5.96 Million |
-0.081x | +24.17% |
| 2024-12-31 | €52.70 Million ≈ $61.61 Million |
€-5.62 Million ≈ $-6.57 Million |
-0.107x | -30.81% |
| 2023-12-31 | €61.80 Million ≈ $72.25 Million |
€-5.04 Million ≈ $-5.89 Million |
-0.082x | -75.66% |
| 2022-12-31 | €70.98 Million ≈ $82.98 Million |
€-3.30 Million ≈ $-3.85 Million |
-0.046x | -33.17% |
| 2021-12-31 | €77.86 Million ≈ $91.02 Million |
€-2.71 Million ≈ $-3.17 Million |
-0.035x | -76.37% |
| 2020-12-31 | €19.57 Million ≈ $22.88 Million |
€-387.00K ≈ $-452.44K |
-0.020x | +85.29% |
| 2019-12-31 | €5.51 Million ≈ $6.44 Million |
€-741.00K ≈ $-866.31K |
-0.134x | -- |
About Afyren SAS
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. It offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. The company's products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermo… Read more